Avoid common mistakes on your manuscript.
1 Correction to: Clinical Drug Investigation (2022) 42:631–642 https://doi.org/10.1007/s40261-022-01178-y
The original version of this article unfortunately contained a mistake. Page 638, Fig. 1, right top box, second bullet point, which previously read:
PSADT > 10 months
Should read:
PSADT < 10 months
The corrected Fig. 1 is given in the following page.
Individual patient clinical approach algorithm. CT computed tomography, M0 CRPC nonmetastatic castration-resistant prostate cancer, PSA prostate-specific antigen, PSADT PSA doubling time
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Figueiredo, A., Costa, L., Maurício, M.J. et al. Correction to: Nonmetastatic Castration‑Resistant Prostate Cancer: Current Challenges and Trends. Clin Drug Investig 42, 1019–1020 (2022). https://doi.org/10.1007/s40261-022-01212-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40261-022-01212-z